1,799
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Association of serum 25-Hydroxy Vitamin D level with lipid, lipoprotein, and apolipoprotein level

, , , &
Pages 812-816 | Received 06 Apr 2021, Accepted 11 Aug 2021, Published online: 15 Nov 2021

References

  • Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80(6Suppl):1678S–88S.
  • Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81(3):353–373.
  • Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88(2):491S–9S.
  • Holick MF, MacLaughlin JA, Clark MB, et al. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science. 1980;210(4466):203–205.
  • Al Mheid I, Quyyumi AA. Vitamin D and cardiovascular disease: controversy unresolved. J Am Coll Cardiol. 2017;70(1):89–100.
  • Ponda MP, Huang X, Odeh MA, et al. Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation. 2012;126(3):270–277.
  • Koba S, Yokota Y, Hirano T, et al. Small LDL-cholesterol is superior to LDL-cholesterol for determining severe coronary atherosclerosis. J Atheroscler Thromb. 2008;15(5):250–260.
  • Higashioka M, Sakata S, Honda T, et al. The association of small dense low-density lipoprotein cholesterol and coronary heart disease in subjects at high cardiovascular risk. J Atheroscler Thromb. 2020;28(1):79-89.
  • Duran EK, Aday AW, Cook NR, et al. Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease. J Am Coll Cardiol. 2020;75(17):2122–2135.
  • Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 1996;276(11):875–881.
  • Hoogeveen RC, Gaubatz JW, Sun W, et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014;34(5):1069–1077.
  • Zaid M, Fujiyoshi A, Miura K, et al. High-density lipoprotein particle concentration and subclinical atherosclerosis of the carotid arteries in Japanese men. Atherosclerosis. 2015;239(2):444–450.
  • Christakos S, Dhawan P, Verstuyf A, et al. D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016;96(1):365–408.
  • Kendrick J, Targher G, Smits G, et al. 25-hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the third national health and nutrition examination survey. Atherosclerosis. 2009;205(1):255–260.
  • Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106(7):963–968.
  • Weyland PG, Grant WB, Howie-Esquivel J. Does sufficient evidence exist to support a causal association between vitamin D status and cardiovascular disease risk? An assessment using Hill’s criteria for causality. Nutrients. 2014;6(9):3403–3430.
  • Tomaschitz A, Pilz S, Ritz E, et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta. 2010;411(17–18):1354–1360.
  • Scragg R, Sowers M, Serum BC. 25-hydroxyvitamin D, ethnicity, and blood pressure in the third national health and nutrition examination survey. Am J Hypertens. 2007;20(7):713–719.
  • Berridge MJ. Vitamin D deficiency and diabetes. Biochem J. 2017;474(8):1321–1332.
  • Kim DH, Meza Ca, Clarke H, et al. Vitamin D and endothelial function. Nutrients. 2020;12(2):575.
  • Wang Y, Si S, Liu J, et al. The associations of serum lipids with Vitamin D status. PLoS One. 2016;11(10):e0165157.
  • Valornut UCMRG, Rodriguez-Rodriguez E, Ortega RM, Gonzalez-Rodriguez LG, et al. Vitamin D deficiency is an independent predictor of elevated triglycerides in Spanish school children. Eur J Nutr. 2011;50(5):373–378.
  • Hirschler V, Maccallini G, Molinari C, et al.; San Antonio de los Cobres Study G. Association between vitamin D and Apo B concentrations in Argentinean Indian children. Clin Chim Acta. 2014;429:147–151.
  • Ge H, Sun H, Wang T, et al. The association between serum 25-hydroxyvitamin D3 concentration and serum lipids in the rural population of China. Lipids Health Dis. 2017;16(1):215.
  • Auwerx J, Bouillon R, Kesteloot H. Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb. 1992;12(6):671–674.
  • Walldius G, Jungner I, Aastveit AH, et al. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med. 2004;42(12):1355–1363.
  • Khan S, Pereira BJ. Hematocrit level associated mortality in hemodialysis patients, by Ma JZ, Ebben J, Xia H, Collins AJ. J Am Soc Nephrol. 1999;10:610–619. Semin Dial. 2000;13(2):112-3.
  • Shirts BH, Howard MT, Hasstedt SJ, et al. Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterol. Atherosclerosis. 2012;222(1):167–174.
  • Wang L, Song Y, Manson JE, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5(6):819–829.
  • Dziedzic EA, Przychodzen S, Dabrowski M. The effects of vitamin D on severity of coronary artery atherosclerosis and lipid profile of cardiac patients. Arch Med Sci. 2016;12(6):1199–1206.
  • Dziedzic EA, Gasior JS, Pawlowski M, et al. Vitamin D level is associated with severity of coronary artery atherosclerosis and incidence of acute coronary syndromes in non-diabetic cardiac patients. Arch Med Sci. 2019;15(2):359–368.
  • Fraser A, Williams D, Lawlor DA. Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001-2006). PLoS One. 2010;5(11):e13882.
  • Leu M, Vitamin GE. D: epidemiology of cardiovascular risks and events. Best Pract Res Clin Endocrinol Metab. 2011;25(4):633–646.
  • Schottker B, Jorde R, Peasey A, et al. Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the USA. BMJ. 2014;348:g3656.
  • Mirhosseini N, Rainsbury J, Kimball SM. Vitamin D supplementation, serum 25(OH)D concentrations and cardiovascular disease risk factors: a systematic review and meta-analysis. Front Cardiovasc Med. 2018;5:87.
  • Lappe JM, Heaney RP. Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermatoendocrinol. 2012;4(2):95–100.
  • Jafari T, Fallah AA, Barani A. Effects of vitamin D on serum lipid profile in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Clin Nutr. 2016;35(6):1259–1268.